An open-label, Multinational, Phase IIIb Study to Evaluate Patient and Satisfaction, Safety and Efficacy of Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer (ML28851) in Adjuvant/Neo-Adjuvant Setting

Cicin I., Oukkal M., Mahfouf H., Mezlini A., Larbaoui B., Slim B. A., ...More

11th European Breast Cancer Conference (EBCC), Barcelona, Spain, 21 - 23 March 2018, vol.92, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 92
• Doi Number: 10.1016/s0959-8049(18)30535-5
• City: Barcelona
• Country: Spain
• Istanbul University Affiliated: Yes